Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

Television presenter James Corden claimed the controversial drug - traditionally used to treat type II diabetes - 'didn't ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

James Cordon has spoken out about using Ozempic and shared with the world his findings. While speaking with guest Richard ...

On Tuesday, U.S. Senator Mike Braun (R-Ind.) questioned Novo Nordisk CEO Lars Fruergaard Jørgensen at the Senate Health, ...

Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...

Did she gain the weight back? Here's what she says, plus more mindful takeaways for the reported 15 million Americans who ...

James Corden revealed that he gave Ozempic a try to help with weight loss, but soon found that his relationship with food had ...

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where Viking ...

Sen. Bernie Sanders (I-Vt.) noted that Novo Nordisk’s weight loss drug Ozempic sells for $969 a month in the U.S. but for ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.